Arterial structural modifications in hypertension: Effects of treatment

European Heart Journal

Volumn 18, Issue SUPPL.5, 1997, Pages

  Thom, S ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Carotid artery; Hypertension; Regression; Retina; Vascular geometry; Vascular structure

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTERY RESISTANCE; CARDIOVASCULAR RISK; CAROTID ARTERY; CONFERENCE PAPER; HUMAN; HYPERTENSION; INTIMA; MICROVASCULARIZATION; PRIORITY JOURNAL; RETINA ARTERY; VASCULAR RESISTANCE; VASCULARIZATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARTERIES; CALCIUM CHANNEL BLOCKERS; HUMANS; HYPERTENSION; VASCULAR RESISTANCE;

EID: 0030690406     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(97)90001-4     Document Type: Article

References (42)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-6.
2. Zweibel WJ. High resolution B-mode and duplex carotid sonography. In: Zweibel WJ, ed. Introduction to vascular sonography. New York: Grune & Stratton, 1982: 103-9.
3. Pignoli P, Temoli E, Poli A, Oreste P, Paoletti R. Intimai plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-406.
4. Hughes AD, Sinclair A-M, Geroulakos G et al. Structural changes in the cardiovascular system of untreated essential hypertensives. Blood Pressure 1995; 4: 42 7.
5. Heiss G, Sharrett R, Barnes R et al. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991; 134: 250-6.
6. Roman MJ, Saba PS, Pini R et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909-18.
7. Poli A, Tremoli E, Colombo A et al. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. Arteriosclerosis 1988; 70: 253-61.
8. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1992; 11: 1245-9.
9. Bots ML, Van Swieten JC, Breteler MMB et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 1993; 341: 1232-7.
10. Strauer BE. Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 1979; 44: 999-1006.
11. Mayet J, Stanton AV, Sinclair A-M et al. The effects of antihypertensive therapy on carotid vascular structure in man. Cardiovasc Res 1995; 30: 147-52.
12. Safar ME, Laurent S, Bouthier JD, London GM, Mimran A. Effect of converting enzyme inhibitors on hypertensive large arteries in humans. Am J Hypertens 1986; 8: 1257-61.
13. Asmar RG, Pannier B, Santoni JPH et al. Reversion of hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation 1988; 78: 941-50.
14. Van Merode T, Van Bortel L, Smeets FA et al. The effect of verapamil on carotid artery distensibility and cross-sectional compliance in hypertensive patients. J Cardiovasc Pharmacol 1990; 15: 103-9.
15. Ornish D, Brown SE, Scherwitz LW et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336: 129-33.
16. Blankenhorn DH, Selzer RH, Crawford DW et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation 1993; 88: 20-8.
17. Crouse JR, Byington RP, Bond MG et al. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II). Am J Cardiol 1995; 75: 455-9.
18. Short D. Morphology of the intestinal arterioles in chronic human hypertension. Br Heart J 1966; 28: 184-92.
19. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990; 70: 921-61.
20. Folkow B, Grimby G, Thulesius O. Adaptative structural changes of the vascular walls in hypertension and their relation to the control of peripheral resistance. Acta Physiol Scand 1958; 44: 255-72.
21. Conway J. A vascular abnormality in hypertension, a study of blood flow in the forearm. Circulation 1963; 27: 520-9.
22. Furuyama M. Histometrical investigations of arteries in reference to arterial hypertension. Tohoku J Exp Med 1962; 76: 388-414.
23. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987; 61: 181-6.
24. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62: 347-504.
25. Jennings GL, Esler MD, Korner PI. Effect of prolonged treatment on haemodynamic of essential hypertension before and after autonomie blockade. Lancet 1980; ii: 166-9.
26. Wikstrand J, Trimarco B, Ricciardelli B, de Luca N, Volpe M. Reversal of structural cardiovascular changes by antihypertensive treatment: functional consequences and time course of reversal as judged from clinical studies. In: Folkow B, ed. Hypertension, Pathophysiology and clinical implications of early structural changes. Sweden: AB Hässle, 1983: 348-70.
27. Heagerty AM, Bund SJ, Aalkjaer C. The effects of drug therapy upon human resistance arteriole morphology in essential hypertension. Lancet 1988; ii: 1209-12.
28. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995; 25 (4 Pt 1): 474-81.
29. Schiffrin EL, Deng LY, Larochelle P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker. Am J Hypertens 1995; 8: 229-36.
30. Hartford M, Wendelhag I, Berglund G, Wallentin I, Ljungman S, Wikstrand J. Cardiovascular and renal effects of long-term antihypertensive treatment. JAMA 1988; 259: 2553-7.
31. Landau J, Davis E. Capillary thinning and high capillary blood pressure in hypertension. Lancet 1957; i: 1327-30.
32. Harper RN, Moore MA, Marr MC, Watts LE, Hutchins PM. Arteriolar rarefaction in the conjunctiva of human essential hypertension. Microvasc Res 1978; 16: 369-72.
33. Davis E. Clinical method for measuring capillary blood pressure. Arch Int Med 1953; 91: 715-25.
34. Henrich HA, Romen W, Heimgärtner W, Hartung E, Bäumer F. Capillary rarefaction characteristic of the skeletal muscle of hypertensive patients. Klin Wochenschr 1988; 66: 54-60.
35. Hansen-Smith F, Greene AS, Cowley AW, Lombard JH. Structural changes during microvascular rarefaction in chronic hypertension. Hypertension 1990; 15: 922-8.
36. Sullivan JM, Prewitt RL, Josephs JA. Attenuation of the microcirculation in young patients with high-output borderline hypertension. Hypertension 1983; 5: 844-51.
37. Takeshita A, Imaizumi T, Ashihara T, Yamamoto K, Hoka S, Nakamura M. Limited maximal vasodilator capacity of forearm resistance vessels in normotensive young men with a family disposition to hypertension. Circ Res 1982; 50: 671-7.
38. Stanton AV, Wasan B, Cerutti A et al. Vascular network changes in the retina with age and hypertension. J Hypertens 1995; 13: 1724-8.
39. King L, Stanton AV, Sever PS, Thom S, Hughes A. Lengthdiameter ratio: a geometric parameter of the retinal vasculature diagnostic of hypertension. J Human Hypertens 1996; 10: 417-8.
40. Struijker Boudier HAJ, le Noble JLML, Messing MWJ, Huijberts MSP, le Noble FAC, van Essen H. The microcirculation and hypertension. J Hypertens 1992; 10 (Suppl 7): 147s-156s.
41. Chapman N, Mohamudally A, Stanton A et al. Vascular network geometry - the missing link between birth weight and cardiovascular risk? Hypertension 1996; 28: 703.
42. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994; 90: 1786-93.